[go: up one dir, main page]

AU2001276409A1 - Medicaments containing cilansetron for treating non-obstipated male ibs patients - Google Patents

Medicaments containing cilansetron for treating non-obstipated male ibs patients

Info

Publication number
AU2001276409A1
AU2001276409A1 AU2001276409A AU7640901A AU2001276409A1 AU 2001276409 A1 AU2001276409 A1 AU 2001276409A1 AU 2001276409 A AU2001276409 A AU 2001276409A AU 7640901 A AU7640901 A AU 7640901A AU 2001276409 A1 AU2001276409 A1 AU 2001276409A1
Authority
AU
Australia
Prior art keywords
obstipated
treating non
medicaments containing
ibs patients
male ibs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276409A
Other languages
English (en)
Inventor
Egbertus Hendrikus Evert Biesheuvel
Steven David Caras
Werner Cautreels
Heinz Gunter Krause
Albertus Hermannus Dirk Plekkenpol
Claus Rudolf Steinborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Products GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10123447A external-priority patent/DE10123447A1/de
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Publication of AU2001276409A1 publication Critical patent/AU2001276409A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001276409A 2000-07-26 2001-07-18 Medicaments containing cilansetron for treating non-obstipated male ibs patients Abandoned AU2001276409A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10036645 2000-07-26
DE10036645 2000-07-26
DE10123447A DE10123447A1 (de) 2000-07-26 2001-05-14 Cilansetron enthaltende Arzneimittel zur Behandlung nicht-obstipativer männlicher IBS-Patienten
DE10123447 2001-05-14
PCT/EP2001/008260 WO2002007713A2 (fr) 2000-07-26 2001-07-18 Medicament contenant du cilansetron pour traiter des patients masculins atteints du syndrome du colon irritable mais ne souffrant pas de constipation opiniatre

Publications (1)

Publication Number Publication Date
AU2001276409A1 true AU2001276409A1 (en) 2002-02-05

Family

ID=26006529

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276409A Abandoned AU2001276409A1 (en) 2000-07-26 2001-07-18 Medicaments containing cilansetron for treating non-obstipated male ibs patients

Country Status (16)

Country Link
EP (1) EP1307195A2 (fr)
JP (1) JP2004504343A (fr)
CN (1) CN1444479A (fr)
AR (1) AR028970A1 (fr)
AU (1) AU2001276409A1 (fr)
BR (1) BR0112690A (fr)
CA (1) CA2417677A1 (fr)
CZ (1) CZ2003158A3 (fr)
HU (1) HUP0301479A2 (fr)
IL (1) IL153972A0 (fr)
MX (1) MXPA02012917A (fr)
NO (1) NO20030373L (fr)
PL (1) PL363517A1 (fr)
RU (1) RU2003104798A (fr)
SK (1) SK1272003A3 (fr)
WO (1) WO2002007713A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0216027D0 (en) 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
WO2005073220A1 (fr) * 2004-01-30 2005-08-11 Yamanouchi Pharmaceutical Co., Ltd. Remede contre le syndrome du colon irritable avec diarrhee
WO2005072730A1 (fr) * 2004-01-30 2005-08-11 Astellas Pharma Inc. Agent therapeutique pour le syndrome de l’intestin irritable de type diarrhoe
JP4632204B2 (ja) * 2005-09-21 2011-02-16 アステラス製薬株式会社 下痢型過敏性腸症候群治療剤
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721139D0 (en) * 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
GB9930077D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
BR0112690A (pt) 2003-06-24
CA2417677A1 (fr) 2003-01-27
IL153972A0 (en) 2003-07-31
MXPA02012917A (es) 2003-05-14
CN1444479A (zh) 2003-09-24
SK1272003A3 (en) 2003-07-01
AR028970A1 (es) 2003-05-28
NO20030373D0 (no) 2003-01-24
JP2004504343A (ja) 2004-02-12
PL363517A1 (en) 2004-11-29
NO20030373L (no) 2003-01-24
WO2002007713A3 (fr) 2002-11-14
HUP0301479A2 (hu) 2003-09-29
CZ2003158A3 (cs) 2003-08-13
EP1307195A2 (fr) 2003-05-07
RU2003104798A (ru) 2004-06-27
WO2002007713A2 (fr) 2002-01-31

Similar Documents

Publication Publication Date Title
AU2002221239A1 (en) Therapeutic benzimidazole compounds
AU2001253265A1 (en) Oral treatment systems
AU2001275511A1 (en) Guide for medical devices
AU2002222853A1 (en) Therapeutic compounds
AU2001234425A1 (en) Multi-lumen medical device
AU3668600A (en) Phytoestrogen supplements
AU2001280030A1 (en) Illuminating devices for medical use
AU2001284444A1 (en) Preparations for oral administration
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
AU2001247841A1 (en) Medical procedure
AU2000265525A1 (en) Medicament for treating intestinal diseases
AU2001248943A1 (en) Pharmaceutical curative compound
AU2001256201A1 (en) Device for administering implants
AU4364400A (en) Azaindole derivatives for the treatment of depression
AU2001243515A1 (en) Combination drug therapy
AU2001276409A1 (en) Medicaments containing cilansetron for treating non-obstipated male ibs patients
AU3945501A (en) Apparatus for dosage of medicaments
AUPQ692300A0 (en) Phototherapy eyeshield for babies
AU2001233706A1 (en) Container for medicaments
AU3567500A (en) Photodynamic therapy compounds
AU5882600A (en) Medical sterilizer
AU2001266282A1 (en) Sterilization apparatus
AU2000263936A1 (en) Substance p analogs for the treatment of cancer
AU2001287884A1 (en) Halogen compounds for use in medicine
AU2136500A (en) Preparation for dental treatment